Zobrazeno 1 - 10
of 147
pro vyhledávání: '"Karola Vorauer-Uhl"'
Autor:
Dominik Damm, Ehsan Suleiman, Hannah Theobald, Jannik T. Wagner, Mirjam Batzoni, Bianca Ahlfeld (née Kohlhauser), Bernd Walkenfort, Jens-Christian Albrecht, Jidnyasa Ingale, Lifei Yang, Mike Hasenberg, Richard T. Wyatt, Karola Vorauer-Uhl, Klaus Überla, Vladimir Temchura
Publikováno v:
Pharmaceutics, Vol 14, Iss 7, p 1385 (2022)
Functionalization of experimental HIV-1 virus-like particle vaccines with heterologous T helper epitopes (T helper VLPs) can modulate the humoral immune response via intrastructural help (ISH). Current advances in the conjugation of native-like HIV-1
Externí odkaz:
https://doaj.org/article/d6bcf5265dc047d3a53880797af39283
Autor:
Ehsan Suleiman, Dominik Damm, Mirjam Batzoni, Vladimir Temchura, Andreas Wagner, Klaus Überla, Karola Vorauer-Uhl
Publikováno v:
Pharmaceutics, Vol 11, Iss 11, p 619 (2019)
Since the first use of liposomes as carriers for antigens, much work has been done to elucidate the mechanisms involved in the encapsulation of vaccine-relevant biomolecules. However, only a few studies have specifically investigated the encapsulatio
Externí odkaz:
https://doaj.org/article/51607de900f64ee6800d94a705cae2fa
Publikováno v:
Biotechnology progressREFERENCES. 38(5)
Glycation on lysine side chains of recombinant monoclonal antibodies (mAb) is a well-known phenomenon in manufacturing processes of biopharmaceuticals that potentially alter the efficacy of the therapeutic protein. In the present study, we report kin
Glycation on lysine side chains of recombinant monoclonal antibodies (mAb) is a well known phenomenon in manufacturing processes of biopharmaceuticals that potentially alter the efficacy of the therapeutic protein. Previously, we reported a method to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dd1b29af97feba666a2a59263435ff8
https://doi.org/10.22541/au.163506359.97922307/v1
https://doi.org/10.22541/au.163506359.97922307/v1
Autor:
Karola Vorauer-Uhl, Gerald Striedner, Bernhard Sissolak, Gabriele Lhota, Wolfgang Sommeregger
Publikováno v:
Biotechnology Progress
Post‐translational, nonenzymatic glycation of monoclonal antibodies (mAbs) in the presence of reducing sugars (in bioprocesses) is a widely known phenomenon, which affects protein heterogeneity and potentially has an impact on quality, safety, and
Autor:
Alexandra Castilho, Laura Neumann, Pia Gattinger, Richard Strasser, Karola Vorauer-Uhl, Thomas Sterovsky, Friedrich Altmann, Herta Steinkellner
Publikováno v:
PLoS ONE, Vol 8, Iss 1, p e54836 (2013)
Hyperglycosylated proteins are more stable, show increased serum half-life and less sensitivity to proteolysis compared to non-sialylated forms. This applies particularly to recombinant human erythropoietin (rhEPO). Recent progress in N-glycoengineer
Externí odkaz:
https://doaj.org/article/b5f06cfea02040d2973c071052b72e7a
Autor:
Ehsan, Suleiman, Julia, Mayer, Elisabeth, Lehner, Bianca, Kohlhauser, Alexandra, Katholnig, Mirjam, Batzoni, Dominik, Damm, Vladimir, Temchura, Andreas, Wagner, Klaus, Überla, Karola, Vorauer-Uhl
Publikováno v:
Pharmaceutics
The display of native-like human immunodeficiency virus type 1 envelope (HIV-1 Env) trimers on liposomes has gained wide attention over the last few years. Currently, available methods have enabled the preparation of Env-liposome conjugates of unprec
Autor:
Jakob Wallner, Krisztina Koczka, Karola Vorauer-Uhl, Lisa Nika, Reingard Grabherr, Dieter Palmberger
Publikováno v:
Protein Expression and Purification. 136:27-38
Biomarkers of cancer are often glycosylated membrane receptor proteins present on the cellular surface. In order to develop new antibodies for cancer diagnostics or treatment, it is a main pre-requisite that these target proteins are available in a n